Hopes rekindle: Serum Institute seeks DCGI permission for phase 2/3 clinical trials of Oxford University’s COVID-19 ‘vaccine’
New Delhi: Serum Institute of India (SII) has partnered with ‘AstraZeneca’ for manufacturing the Oxford vaccine candidate for COVID-19. Serum...











































